{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T20:31:45Z","timestamp":1774643505546,"version":"3.50.1"},"reference-count":106,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.cll.2006.06.005","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T14:29:29Z","timestamp":1168439369000},"page":"635-653","source":"Crossref","is-referenced-by-count":57,"title":["Microalbuminuria"],"prefix":"10.1016","volume":"26","author":[{"given":"Nitin","family":"Khosla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pantelis A.","family":"Sarafidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George L.","family":"Bakris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6720","key":"10.1016\/j.cll.2006.06.005_bib1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/bmj.300.6720.297","article-title":"Microalbuminuria as predictor of increased mortality in elderly people","volume":"300","author":"Damsgaard","year":"1990","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.cll.2006.06.005_bib2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1056\/NEJM198402093100605","article-title":"Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes","volume":"310","author":"Mogensen","year":"1984","journal-title":"N Engl J Med"},{"issue":"8287","key":"10.1016\/j.cll.2006.06.005_bib3","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/S0140-6736(82)92450-3","article-title":"Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus","volume":"1","author":"Viberti","year":"1982","journal-title":"Lancet"},{"issue":"8610","key":"10.1016\/j.cll.2006.06.005_bib4","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0140-6736(88)92657-8","article-title":"Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey","volume":"2","author":"Yudkin","year":"1988","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cll.2006.06.005_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00041552-199605000-00006","article-title":"Microalbuminuria: prognostic implications","volume":"5","author":"Bakris","year":"1996","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"13","key":"10.1016\/j.cll.2006.06.005_bib6","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/archinte.1997.00440340025002","article-title":"The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature","volume":"157","author":"Dinneen","year":"1997","journal-title":"Arch Intern\u00a0Med"},{"issue":"4","key":"10.1016\/j.cll.2006.06.005_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/sj.jhh.1000594","article-title":"Microalbuminuria and cardiovascular risk: a word of caution","volume":"12","author":"Gosling","year":"1998","journal-title":"J Hum Hypertens"},{"issue":"6","key":"10.1016\/j.cll.2006.06.005_bib8","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1464-5491.1995.tb00528.x","article-title":"The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study","volume":"12","author":"Mathiesen","year":"1995","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.cll.2006.06.005_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1464-5491.1995.tb00446.x","article-title":"Proteinuria and mortality in diabetes: the WHO Multinational Study of Vascular Disease in Diabetes","volume":"12","author":"Stephenson","year":"1995","journal-title":"Diabet Med"},{"issue":"9","key":"10.1016\/j.cll.2006.06.005_bib10","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.2337\/diacare.15.9.1216","article-title":"Diabetic nephropathy. Future avenue","volume":"15","author":"Viberti","year":"1992","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.cll.2006.06.005_bib11","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0272-6386(95)90636-3","volume":"25","author":"Bennett","year":"1995","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.cll.2006.06.005_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/j.1524-6175.2004.04237.x","article-title":"Comparison of commonly used assays for the detection of microalbuminuria","volume":"6","author":"Busby","year":"2004","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"3","key":"10.1016\/j.cll.2006.06.005_bib13","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00004872-199403000-00013","article-title":"Microalbuminuria in elderly hypertensives: reproducibility and relation to clinic and ambulatory blood pressure","volume":"12","author":"James","year":"1994","journal-title":"J Hypertens"},{"issue":"11","key":"10.1016\/j.cll.2006.06.005_bib14","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2337\/diacare.16.11.1485","article-title":"Microalbuminuria in a middle-aged workforce. Effect of hyperglycemia and ethnicity","volume":"16","author":"Metcalf","year":"1993","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.cll.2006.06.005_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/1056-8727(94)90033-7","article-title":"Epidemiology of microalbuminuria in the general population","volume":"8","author":"Metcalf","year":"1994","journal-title":"J\u00a0Diabetes Complications"},{"issue":"6497","key":"10.1016\/j.cll.2006.06.005_bib16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1136\/bmj.291.6497.693","article-title":"Normal variations in rate of albumin excretion and albumin to creatinine ratios in overnight and daytime urine collections in non-diabetic children","volume":"291","author":"Rowe","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"3","key":"10.1016\/j.cll.2006.06.005_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.7326\/0003-4819-125-3-199608010-00007","article-title":"Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists","volume":"125","author":"Bakris","year":"1996","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.cll.2006.06.005_bib18","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1681\/ASN.V1341034","article-title":"Use of the albumin\/creatinine ratio to detect microalbuminuria: implications of sex and race","volume":"13","author":"Mattix","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.cll.2006.06.005_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0272-6386(89)80112-X","article-title":"Biologic variation of urinary albumin: consequences for analysis, specimen collection, interpretation of results, and screening programs","volume":"13","author":"Howey","year":"1989","journal-title":"Am J Kidney Dis"},{"issue":"17","key":"10.1016\/j.cll.2006.06.005_bib20","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1001\/archinte.158.17.1933","article-title":"Microalbuminuria in nondiabetic adults: relation\u00a0of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study","volume":"158","author":"Cirillo","year":"1998","journal-title":"Arch Intern Med"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2006.06.005_bib21","first-page":"26","article-title":"Detecting microalbuminuria by urinary albumin\/creatinine concentration ratio","volume":"12","author":"Jensen","year":"1997","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.cll.2006.06.005_bib22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00041552-199405000-00004","article-title":"Epidemiology of microalbuminuria in diabetes and in the background population","volume":"3","author":"Mogensen","year":"1994","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.cll.2006.06.005_bib23","first-page":"S163","article-title":"Microalbuminuria: a marker of cardiovascular risk and organ damage in essential hypertension","volume":"63","author":"Pontremoli","year":"1997","journal-title":"Kidney Int Suppl"},{"issue":"9200","key":"10.1016\/j.cll.2006.06.005_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators","volume":"355","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cll.2006.06.005_bib25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/1056-8727(94)90032-9","article-title":"Albuminuria in normals and essential hypertension","volume":"8","author":"Mimran","year":"1994","journal-title":"J Diabetes Complications"},{"issue":"9 Pt 2","key":"10.1016\/j.cll.2006.06.005_bib26","doi-asserted-by":"crossref","first-page":"189S","DOI":"10.1016\/S0895-7061(97)00152-0","article-title":"Microalbuminuria, blood pressure, metabolic control, and renal involvement: longitudinal studies in white non-insulin-dependent diabetic patients","volume":"10","author":"Schmitz","year":"1997","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.cll.2006.06.005_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1523-1755.2003.00712.x","article-title":"Development and progression of nephropathy in type 2 diabetes: Prospective Diabetes Study (UKPDS 64)","volume":"63","author":"Adler","year":"2003","journal-title":"Kidney Int"},{"issue":"25","key":"10.1016\/j.cll.2006.06.005_bib28","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.cll.2006.06.005_bib29","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000186842","article-title":"Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension","volume":"61","author":"Bigazzi","year":"1992","journal-title":"Nephron"},{"issue":"2","key":"10.1016\/j.cll.2006.06.005_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archinte.1992.00400140115025","article-title":"Differences in urinary albumin excretion rate between normotensive and hypertensive, white and nonwhite subjects","volume":"152","author":"Gerber","year":"1992","journal-title":"Arch Intern Med"},{"issue":"7868","key":"10.1016\/j.cll.2006.06.005_bib31","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/S0140-6736(74)91002-2","article-title":"Increased urinary albumin-excretion rate in benign essential hypertension","volume":"1","author":"Parving","year":"1974","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.cll.2006.06.005_bib32","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1523-1755.2003.00164.x","article-title":"Lipoproteins in the DCCT\/EDIC cohort: associations with diabetic nephropathy","volume":"64","author":"Jenkins","year":"2003","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.cll.2006.06.005_bib33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.diabres.2004.03.011","article-title":"LDL particle size and lipid composition are risk factors for microalbuminuria in normotensive and normocholesterolemic patients with type 2 diabetes","volume":"66","author":"Matsui","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.cll.2006.06.005_bib34","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1046\/j.1523-1755.2001.00487.x","article-title":"Effect of lipid reduction on the progression of renal disease: a meta-analysis","volume":"59","author":"Fried","year":"2001","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.cll.2006.06.005_bib35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/030006059402200401","article-title":"Microalbuminuria: pathogenesis, prognosis and management","volume":"22","author":"Panayiotou","year":"1994","journal-title":"J Int Med Res"},{"issue":"6","key":"10.1016\/j.cll.2006.06.005_bib36","first-page":"285","article-title":"Microalbuminuria: a marker of systemic disease","volume":"54","author":"Gosling","year":"1995","journal-title":"Br J Hosp Med"},{"issue":"9","key":"10.1016\/j.cll.2006.06.005_bib37","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1161\/01.ATV.15.9.1324","article-title":"Renal and systemic transvascular albumin leakage in severe atherosclerosis","volume":"15","author":"Jensen","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.cll.2006.06.005_bib38","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2337\/diacare.15.9.1181","article-title":"Microalbuminuria. Implications for micro- and macrovascular disease","volume":"15","author":"Deckert","year":"1992","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.cll.2006.06.005_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0008-6363(96)00272-6","article-title":"Endothelial dysfunction and pathogenesis of diabetic angiopathy","volume":"34","author":"Stehouwer","year":"1997","journal-title":"Cardiovasc Res"},{"issue":"10","key":"10.1016\/j.cll.2006.06.005_bib40","first-page":"601","article-title":"Evidence of oxidant injury and tubular damage in early diabetic nephropathy","volume":"87","author":"Yaqoob","year":"1994","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.cll.2006.06.005_bib41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00041552-199605000-00010","article-title":"Update on pathogenesis, markers and management of diabetic nephropathy","volume":"5","author":"Mogyorosi","year":"1996","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"Suppl 3","key":"10.1016\/j.cll.2006.06.005_bib42","first-page":"610","article-title":"Microalbuminuria as a marker of cardiovascular and renal disease in essential hypertension","volume":"10","author":"Bigazzi","year":"1995","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.cll.2006.06.005_bib43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/1056-8727(95)80019-B","article-title":"Localization of advanced glycation endproducts in the kidney of experimental diabetic rats","volume":"9","author":"Shikata","year":"1995","journal-title":"J Diabetes Complications"},{"issue":"1","key":"10.1016\/j.cll.2006.06.005_bib44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ajh\/7.1.23","article-title":"Diurnal variations of blood pressure and microalbuminuria in essential hypertension","volume":"7","author":"Bianchi","year":"1994","journal-title":"Am J Hypertens"},{"issue":"11","key":"10.1016\/j.cll.2006.06.005_bib45","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/oxfordjournals.ndt.a027119","article-title":"Microalbuminuria in essential hypertension\u2014its relation to cardiovascular risk factors","volume":"11","author":"Pontremoli","year":"1996","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.cll.2006.06.005_bib46","first-page":"65","article-title":"Banting Lecture 1988. Role of insulin resistance in human disease. 1988","volume":"13","author":"Reaven","year":"1997","journal-title":"Nutrition"},{"issue":"6","key":"10.1016\/j.cll.2006.06.005_bib47","article-title":"Elevated serum insulin levels in patients with essential hypertension and microalbuminuria","volume":"23","author":"Bianchi","year":"1994","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.cll.2006.06.005_bib48","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2337\/diabetes.47.5.793","article-title":"Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study","volume":"47","author":"Mykkanen","year":"1998","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.cll.2006.06.005_bib49","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1464-5491.2004.01408.x","article-title":"A comparison of urinary albumin excretion rate and microalbuminuria in various glucose tolerance subjects","volume":"22","author":"Wang","year":"2005","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.cll.2006.06.005_bib50","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0272-6386(04)01079-0","article-title":"Albuminuria is evident in the early stages of diabetes onset: results from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab)","volume":"44","author":"Tapp","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.cll.2006.06.005_bib51","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s001250050970","article-title":"Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study","volume":"41","author":"Jager","year":"1998","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.cll.2006.06.005_bib52","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/01.CIR.91.3.831","article-title":"Hyperinsulinemic microalbuminuria. A new risk indicator for coronary heart disease","volume":"91","author":"Kuusisto","year":"1995","journal-title":"Circulation"},{"issue":"8815","key":"10.1016\/j.cll.2006.06.005_bib53","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0140-6736(92)91401-S","article-title":"Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus","volume":"340","author":"Stehouwer","year":"1992","journal-title":"Lancet"},{"issue":"8914","key":"10.1016\/j.cll.2006.06.005_bib54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(94)91047-2","article-title":"Microalbuminuria and endothelial dysfunction in essential hypertension","volume":"344","author":"Pedrinelli","year":"1994","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.cll.2006.06.005_bib55","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1161\/01.CIR.103.14.1869","article-title":"Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects","volume":"103","author":"Clausen","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.cll.2006.06.005_bib56","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0021-9150(01)00748-1","article-title":"Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-mediated vasodilation, in apparently healthy subjects","volume":"163","author":"Diercks","year":"2002","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.cll.2006.06.005_bib57","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0272-6386(99)70002-8","article-title":"Microalbuminuria in essential hypertension: significance, pathophysiology, and therapeutic implications","volume":"34","author":"Bianchi","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.cll.2006.06.005_bib58","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1464-5491.1994.tb00254.x","article-title":"Lipoprotein(a) in type 1 diabetic patients with renal disease","volume":"11","author":"Groop","year":"1994","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.cll.2006.06.005_bib59","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2337\/diacare.29.01.06.dc05-1583","article-title":"Higher levels of HDL cholesterol are associated with a decreased likelihood of albuminuria in patients with long-standing type 1 diabetes","volume":"29","author":"Molitch","year":"2006","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.cll.2006.06.005_bib60","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2337\/diacare.22.7.1165","article-title":"Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes","volume":"22","author":"Sibley","year":"1999","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.cll.2006.06.005_bib61","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0021-9150(94)05443-M","article-title":"Microalbuminuria is not associated with cardiovascular disease in patients with homozygous familial hypercholesterolaemia","volume":"113","author":"Zouvanis","year":"1995","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.cll.2006.06.005_bib62","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1038\/ki.1995.490","article-title":"UK Prospective Diabetes Study. XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM","volume":"48","author":"Dudley","year":"1995","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.cll.2006.06.005_bib63","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2337\/diabetes.43.3.384","article-title":"Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications","volume":"43","author":"Marre","year":"1994","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.cll.2006.06.005_bib64","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/07853899209167005","article-title":"Microalbuminuria: a genetic link between diabetes and cardiovascular disease?","volume":"24","author":"Yudkin","year":"1992","journal-title":"Ann Med"},{"issue":"6","key":"10.1016\/j.cll.2006.06.005_bib65","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1046\/j.1523-1755.2001.00073.x","article-title":"Glomerular mRNAs in human type 1 diabetes: biochemical evidence for microalbuminuria as a manifestation of diabetic nephropathy","volume":"60","author":"Adler","year":"2001","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.cll.2006.06.005_bib66","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00004872-199602000-00011","article-title":"Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension","volume":"14","author":"Agrawal","year":"1996","journal-title":"J Hypertens"},{"issue":"1\u20132","key":"10.1016\/j.cll.2006.06.005_bib67","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0021-9150(92)90201-Q","article-title":"Microalbuminuria and associated cardiovascular risk factors in the community","volume":"93","author":"Winocour","year":"1992","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.cll.2006.06.005_bib68","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.ki.4495353","article-title":"Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study","volume":"54","author":"Hoogeveen","year":"1998","journal-title":"Kidney Int"},{"issue":"13","key":"10.1016\/j.cll.2006.06.005_bib69","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/jama.293.13.1609","article-title":"N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults","volume":"293","author":"Kistorp","year":"2005","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.cll.2006.06.005_bib70","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/sj.jhh.1000503","article-title":"Microalbuminuria in hypertension: is it up to measure?","volume":"11","author":"Lydakis","year":"1997","journal-title":"J Hum Hypertens"},{"issue":"1","key":"10.1016\/j.cll.2006.06.005_bib71","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2337\/diacare.19.1.79","article-title":"Microalbuminuria in patients with NIDDM: an overview","volume":"19","author":"Alzaid","year":"1996","journal-title":"Diabetes Care"},{"issue":"23","key":"10.1016\/j.cll.2006.06.005_bib72","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1001\/jama.290.23.3101","article-title":"Screening for proteinuria in US adults: a cost-effectiveness analysis","volume":"290","author":"Boulware","year":"2003","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.cll.2006.06.005_bib73","doi-asserted-by":"crossref","first-page":"901","DOI":"10.7326\/0003-4819-139-11-200312020-00008","article-title":"Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study","volume":"139","author":"Wachtell","year":"2003","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.cll.2006.06.005_bib74","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/archinte.165.8.947","article-title":"The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension","volume":"165","author":"Lea","year":"2005","journal-title":"Arch Intern Med"},{"issue":"19","key":"10.1016\/j.cll.2006.06.005_bib75","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.cll.2006.06.005_bib76","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0002-9149(97)00312-3","article-title":"Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group","volume":"80","author":"Agewall","year":"1997","journal-title":"Am J Cardiol"},{"issue":"4","key":"10.1016\/j.cll.2006.06.005_bib77","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ki.1992.128","article-title":"Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study","volume":"41","author":"Messent","year":"1992","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.cll.2006.06.005_bib78","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/j.ajkd.2004.10.019","article-title":"Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy","volume":"45","author":"Atkins","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.cll.2006.06.005_bib79","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/j.1523-1755.2004.00653.x","article-title":"Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL","volume":"65","author":"de Zeeuw","year":"2004","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.cll.2006.06.005_bib80","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.cll.2006.06.005_bib81","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/oxfordjournals.eurheartj.a059931","article-title":"Microalbuminuria is an early response following acute myocardial infarction","volume":"12","author":"Gosling","year":"1991","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.cll.2006.06.005_bib82","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0950-821X(05)80815-1","article-title":"Assessment of intermittent claudication by quantitation of exercise-induced microalbuminuria","volume":"4","author":"Hickey","year":"1990","journal-title":"Eur J Vasc Surg"},{"issue":"6","key":"10.1016\/j.cll.2006.06.005_bib83","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1378\/chest.120.6.1984","article-title":"Predictive value of microalbuminuria in medical ICU patients: results of a pilot study","volume":"120","author":"Abid","year":"2001","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.cll.2006.06.005_bib84","doi-asserted-by":"crossref","first-page":"S332","DOI":"10.1097\/00004872-198900076-00162","article-title":"Micro-albuminuria as a predictor of cardiovascular damage in essential hypertension","volume":"7","author":"Cerasola","year":"1989","journal-title":"J Hypertens Suppl"},{"issue":"6","key":"10.1016\/j.cll.2006.06.005_bib85","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/01.ATV.13.6.900","article-title":"Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in nondiabetic atherosclerotic patients","volume":"13","author":"Pedrinelli","year":"1993","journal-title":"Arterioscler Thromb"},{"issue":"9 Pt 1","key":"10.1016\/j.cll.2006.06.005_bib86","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/ajh\/7.9.801","article-title":"Factors related to the presence of microalbuminuria in essential hypertension","volume":"7","author":"Redon","year":"1994","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.cll.2006.06.005_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.2002.33906","article-title":"Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men","volume":"40","author":"Dell'Omo","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.cll.2006.06.005_bib88","first-page":"827","article-title":"Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria","volume":"9","author":"Bigazzi","year":"1995","journal-title":"J Hum Hypertens"},{"issue":"9","key":"10.1016\/j.cll.2006.06.005_bib89","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1161\/01.STR.28.9.1710","article-title":"Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS)","volume":"28","author":"Mykkanen","year":"1997","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.cll.2006.06.005_bib90","first-page":"211","article-title":"High prevalence of hypertensive retinopathy and coronary heart disease in hypertensive patients with persistent microalbuminuria under short intensive antihypertensive therapy","volume":"41","author":"Biesenbach","year":"1994","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.cll.2006.06.005_bib91","doi-asserted-by":"crossref","unstructured":"Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus. American Diabetes Association and the National Kidney Foundation. Diabetes Care 1994;17(11):1357\u201361.","DOI":"10.2337\/diacare.17.11.1357"},{"issue":"7160","key":"10.1016\/j.cll.2006.06.005_bib92","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group","volume":"317","year":"1998","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.cll.2006.06.005_bib93","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-118-8-199304150-00001","article-title":"Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients","volume":"118","author":"Ravid","year":"1993","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.cll.2006.06.005_bib94","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1053\/ajkd.2000.16225","article-title":"Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group","volume":"36","author":"Bakris","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.cll.2006.06.005_bib95","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archinte.1996.00440030080010","article-title":"Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study","volume":"156","author":"Ravid","year":"1996","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.cll.2006.06.005_bib96","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/ki.1993.171","article-title":"Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria","volume":"43","author":"Brown","year":"1993","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.cll.2006.06.005_bib97","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ki.1994.255","article-title":"Effects of different antihypertensive treatments on morphologic progression of diabetic nephropathy in uninephrectomized dogs","volume":"46","author":"Gaber","year":"1994","journal-title":"Kidney Int"},{"issue":"1\u20132","key":"10.1016\/j.cll.2006.06.005_bib98","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0021-9150(96)06045-5","article-title":"Vascular angiotensin-converting enzyme activity in cholesterol-fed rabbits: effects of enalapril","volume":"130","author":"Hoshida","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cll.2006.06.005_bib99","first-page":"S150","article-title":"Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria","volume":"45","author":"Lebovitz","year":"1994","journal-title":"Kidney Int Suppl"},{"issue":"9","key":"10.1016\/j.cll.2006.06.005_bib100","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1097\/00004872-200409000-00026","article-title":"Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy","volume":"22","author":"Ibsen","year":"2004","journal-title":"J Hypertens"},{"issue":"2","key":"10.1016\/j.cll.2006.06.005_bib101","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.semnephrol.2003.11.001","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in chronic renal disease: safety issues","volume":"24","author":"Mangrum","year":"2004","journal-title":"Semin Nephrol"},{"issue":"9352","key":"10.1016\/j.cll.2006.06.005_bib102","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(03)12229-5","article-title":"Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial","volume":"361","author":"Nakao","year":"2003","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.cll.2006.06.005_bib103","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa042167","article-title":"Preventing microalbuminuria in type 2 diabetes","volume":"351","author":"Ruggenenti","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.cll.2006.06.005_bib104","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1161\/01.HYP.0000190585.54734.48","article-title":"Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes","volume":"46","author":"Bakris","year":"2005","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.cll.2006.06.005_bib105","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","article-title":"Progression of chronic kidney disease: the role of\u00a0blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a\u00a0patient-level meta-analysis","volume":"139","author":"Jafar","year":"2003","journal-title":"Ann Intern Med"},{"issue":"9502","key":"10.1016\/j.cll.2006.06.005_bib106","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(05)67814-2","article-title":"Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis","volume":"366","author":"Casas","year":"2005","journal-title":"Lancet"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271206000503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271206000503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T13:03:01Z","timestamp":1628341381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271206000503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":106,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0272271206000503"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2006.06.005","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}